Galectin-3-centered paracrine network mediates cardiac inflammation and fibrosis upon β-adrenergic insult
出版年份 2022 全文链接
标题
Galectin-3-centered paracrine network mediates cardiac inflammation and fibrosis upon β-adrenergic insult
作者
关键词
-
出版物
Science China-Life Sciences
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-30
DOI
10.1007/s11427-022-2189-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Galectin‐3 enhances atrial remodelling and arrhythmogenesis through CD98 signalling
- (2022) Wan‐Li Cheng et al. Acta Physiologica
- Pathophysiology of Takotsubo Syndrome
- (2021) Alexander R. Lyon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Role of the Inflammasome in Heart Failure
- (2021) Jimin Wu et al. Frontiers in Physiology
- The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review
- (2020) Simon W. Rabkin et al. HEART FAILURE REVIEWS
- Pathological matrix stiffness promotes cardiac fibroblast differentiation through the POU2F1 signaling pathway
- (2020) Mingzhe Li et al. Science China-Life Sciences
- Prognostic role of plasma galectin-3 levels in acute coronary syndrome
- (2020) Slayman Obeid et al. European Heart Journal-Acute Cardiovascular Care
- β‐Adrenoceptor stimulation upregulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway
- (2019) Wei‐Bo Zhao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Autophagy mediates the secretion of macrophage migration inhibitory factor from cardiomyocytes upon serum-starvation
- (2019) Jimin Wu et al. Science China-Life Sciences
- The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
- (2019) Philip Joseph et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis
- (2019) Hongsen Chen et al. HEART FAILURE REVIEWS
- Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β2-adrenoceptor overexpression
- (2018) My-Nhan Nguyen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
- (2018) My-Nhan Nguyen et al. Scientific Reports
- Long-Term Prognosis of Patients With Takotsubo Syndrome
- (2018) Jelena R. Ghadri et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult
- (2017) Han Xiao et al. EUROPEAN HEART JOURNAL
- Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling
- (2017) Umesh C. Sharma et al. Heart Lung and Circulation
- Effects of stress on the development and progression of cardiovascular disease
- (2017) Mika Kivimäki et al. Nature Reviews Cardiology
- Early β-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy
- (2016) Toshiaki Isogai et al. HEART
- Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
- (2016) Giuseppe Vergaro et al. HYPERTENSION
- Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts
- (2015) Uri Arad et al. CYTOKINE
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Mortality in takotsubo syndrome is similar to mortality in myocardial infarction — A report from the SWEDEHEART11Swedish web system for enhancement of evidence-based care in heart disease evaluated according to recommended therapies. registry
- (2015) Björn Redfors et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Epidemiology and pathophysiology of Takotsubo syndrome
- (2015) Yoshihiro J. Akashi et al. Nature Reviews Cardiology
- Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
- (2015) Christian Templin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation
- (2015) Miguel Angel Burguillos et al. Cell Reports
- Galectin-3: A Modifiable Risk Factor in Heart Failure
- (2014) Rudolf A. de Boer et al. CARDIOVASCULAR DRUGS AND THERAPY
- Sympathetic Overactivity in Hypertension and Cardiovascular Disease
- (2014) Manolis A.J. et al. Current Vascular Pharmacology
- Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
- (2013) Han Xiao et al. CIRCULATION
- Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice
- (2013) Hao Li et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Targeting inflammatory pathways in myocardial infarction
- (2013) Panagiota Christia et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
- (2013) A. C. MacKinnon et al. GLYCOBIOLOGY
- Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
- (2012) Lili Yu et al. Circulation-Heart Failure
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK-STAT Pathway
- (2010) S.-B. Jeon et al. JOURNAL OF IMMUNOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Galectin-3 Gene Inactivation Reduces Atherosclerotic Lesions and Adventitial Inflammation in ApoE-Deficient Mice
- (2007) Maurice Nachtigal et al. AMERICAN JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More